Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.

about

Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland.

Item

http://www.wikidata.org/entity/Q38717462

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Risk of diabetes and dyslipide ...... t of schizophrenia in Iceland.

@en

type

Item

label

Risk of diabetes and dyslipide ...... t of schizophrenia in Iceland.

@en

prefLabel

Risk of diabetes and dyslipide ...... t of schizophrenia in Iceland.

@en

P1476

Risk of diabetes and dyslipide ...... nt of schizophrenia in Iceland

@en

P2093

Magnús Haraldsson

http://www.w3.org/2001/XMLSchema#string

Oddur Ingimarsson

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.

Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.

A diagnostic interview: the schedule for affective disorders and schizophrenia.

Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.

Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients

P304

496-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08039488.2017.1334821

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James H. MacCabe

Engilbert Sigurdsson

Halldóra Jónsdóttir

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28632422

http://www.w3.org/2001/XMLSchema#string

P921

Iceland

schizophrenia

dyslipidemias